Form 4: Winmark Corp Director Acquires Stock Options
SEC Form 4 Filing
Lawrence A. Barbetta, a director of Winmark Corp, reports the acquisition of stock options and updates to his beneficial ownership.
Summary
- On June 1, 2024, Lawrence A. Barbetta, a director of Winmark Corp, acquired 300 non-employee stock options with an exercise price of $355.90, exercisable starting June 1, 2025, and expiring on June 1, 2034.
- Barbetta also acquired 380 non-employee director stock options with an exercise price of $325.99, exercisable starting June 1, 2024, and expiring on June 1, 2033.
- Following these transactions, Barbetta directly owns 7,641 shares of Winmark Corp common stock.
- He also holds various non-employee director stock options granted between 2018 and 2024, with exercise prices ranging from $134.25 to $446.68 and expiration dates extending to December 11, 2033.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The director's acquisition of stock options suggests confidence in the company, but it's a routine transaction.
Positives
- The director's acquisition of stock options could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.
Stakeholder Impact
- The director's stock option acquisition could positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 12/11/2018 | Grant date of Non-Employee Director Stock Option with exercise price $134.25, expiring 12/11/2027 |
| 06/01/2019 | Grant date of Non-Employee Director Stock Option with exercise price $143.2, expiring 06/01/2028 |
| 12/11/2019 | Grant date of Non-Employee Director Stock Option with exercise price $156, expiring 12/11/2028 |
| 06/01/2020 | Grant date of Non-Employee Director Stock Option with exercise price $164.84, expiring 06/01/2029 |
| 12/16/2020 | Grant date of Non-Employee Director Stock Option with exercise price $176.2, expiring 12/16/2029 |
| 06/01/2021 | Grant date of Non-Employee Director Stock Option with exercise price $143.87, expiring 06/01/2030 |
| 12/14/2021 | Grant date of Non-Employee Director Stock Option with exercise price $183.87, expiring 12/14/2030 |
| 06/01/2022 | Grant date of Non-Employee Director Stock Option with exercise price $195.82, expiring 06/01/2031 |
| 12/13/2022 | Grant date of Non-Employee Stock Option with exercise price $261.32, expiring 12/13/2031 |
| 06/01/2023 | Grant date of Non-Employee Stock Option with exercise price $197.8, expiring 06/01/2032 |
| 12/12/2023 | Grant date of Non-Employee Director Stock Option with exercise price $238.6, expiring 12/12/2032 |
| 06/01/2024 | Date of transaction: acquisition of stock options; Grant date of Non-Employee Stock Option with exercise price $355.9, expiring 06/01/2034; Grant date of Non-Employee Director Stock Option with exercise price $325.99, expiring 06/01/2033 |
| 06/04/2024 | Date of signature for the Form 4 filing. |
| 12/11/2024 | Grant date of Non-Employee Director Stock Option with exercise price $446.68, expiring 12/11/2033 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.